Cathepsin L (CTSL), a cysteine protease, is closely related to tumor occurrence, development, and metastasis, and possibly regulates cancer cell resistance to chemotherapy. miRNAs, especially the miR-200 family, have been implicated in drug-resistant tumors. In this study we explored the relationship of CTSL, miRNA-200c and drug resistance, and the potential regulatory mechanisms in human lung cancer A549 cells and A549/TAX cells in vitro. A549/TAX cells were paclitaxel-resistant A549 cells overexpressing CTSL and characterized by epithelial-mesenchymal transition (EMT). We showed that miRNA-200c and CTSL were reciprocally linked in a feedback loop in these cancer cells. Overexpression of miRNA-200c in A549/TAX cells decreased the expression of CTSL, and enhanced their sensitivity to paclitaxel and suppressed EMT, whereas knockdown of miRNA-200c in A549 cells significantly increased the expression of CTSL, and decreased their sensitivity to paclitaxel and induced EMT. Overexpression of CTSL in A549 cells significantly decreased the expression of miRNA-200c, and reduced their sensitivity to paclitaxel and induced EMT, but these effects were reversed by miRNA-200c, whereas knockdown of CTSL in A549/TAX cells attenuated paclitaxel resistance and remarkably inhibited EMT, but the inhibition of miRNA-200c could reverse these effects. Therefore, miRNA-200c may be involved in regulating paclitaxel resistance through CTSL-mediated EMT in A549 cells, and CTSL and miRNA-200c are reciprocally linked in a feedback loop.
Introduction
The morbidity of lung cancer is currently the highest among the morbidities of all cancer types [1] , and this disease is mainly treated with chemotherapy [2, 3] . However, the application of chemotherapy is limited by therapeutic failure because of treatment resistance [4] . Thus, the mechanism of drug resistance should be elucidated and effective targets should be developed for lung cancer treatment.
Cathepsin L (CTSL) is a cysteine protease belonging to the papain-like family of cysteine proteinases, and this protease is closely related to tumor occurrence, development, and metastasis [5] [6] [7] . CTSL plays an important role in the growth, survival, cycle, migration, and invasion of tumor cells [8] and possibly regulates cancer cell resistance to chemotherapy. Zheng et al suggested that CTSL inhibition in drug-resistant cells facilitates the induction of senescence and the reversal of drug resistance [9] , and CTSL inhibition-mediated drug target stabilization may be an alternative approach to enhance chemotherapeutic efficacy [10] . In our laboratory, CTSL is initially identified as a novel epithelial mesenchymal transition (EMT) regulator, and this protease is involved in the modulation of tumor cell invasion and migration [11] . Then we indicated that CTSL also regulates drug resistance by mediating EMT through its effects on the expression of EMT-associated transcription factors, Snail, Slug, ZEB1, and ZEB2 [12] . The overexpression of CTSL is associated with the chemoresistance and invasion of epithelial ovarian cancer [13] and is related to gefitinib resistance in lung cancer [14] . Increased CTSL levels are associated with the increased chemoresistance of tumor cells and may be applied to gene therapy [15] . Thus, CTSL-mediated EMT may serve as a target to improve the efficacy of chemotherapeutics against lung cancer and other types of malignancies.
MicroRNAs (miRNAs) are small non-protein coding RNAs that modulate important cellular functions through their post-transcriptional regulation of messenger RNAs (mRNAs). miRNAs participate in the regulation of cell differentiation, growth, and death in normal and malignant tissues [16] . The role of miRNAs, especially the miR-200 family, is a crucial research field in drug-resistant tumors. The miRNA-200c family regulates EMT, which is implicated in cancer cell invasion and metastasis and in the drug resistance of many cancer types [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . As a member of the miRNA-200 family, miRNA-200c functions as a key regulator of EMT in numerous cancers and promotes an epithelial phenotype by inhibiting several EMT genes, including ZEB1 and ZEB2 [28] . miRNA-200c expression can regulate EMT in bladder cancer cells and reverse their resistance to epidermal growth factor receptor therapy [29] . miRNA-200c can repress the migration and invasion of gastric cancer SGC-7901 cells [30] and enhance 5-fluorouracil resistance by regulating the expression of dual specificity phosphatase-6 [31] . And it is reported that miRNAs, including miR-23b, miR-551, miR-1464, and miR-1803, control CTSL gene expression at a post-transcriptional level [32] . Nevertheless, the potential role of miRNA-200c in CTSL mediation and drug resistance in A549 cells has yet to be described, and the underlying mechanism has yet to be determined.
On the basis of the previous studies, we aimed to verify the relationship of CTSL, miRNA-200c, and drug resistance and to discuss the potential regulatory mechanism. In the present study, we demonstrated that miRNA-200c can regulate the sensitivity of cells to paclitaxel and EMT. CTSL and miRNA200c are also reciprocally linked in a feedback loop and they reverse paclitaxel resistance by inhibiting EMT in A549/TAX cells.
Materials and methods

Materials
Cell culture reagents and Lipofectamine reagent were purchased from Invitrogen Life Technologies (Carlsbad, CA, USA). Phalloidin was obtained from Sigma-Aldrich (St Louis, MO, USA). The antibodies used in this study were anti-Ncadherin, anti-E-cadherin, anti-Vimentin, and anti-Snail (Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA); anti-CTSL (Abcam); and anti-β-actin (MultiSciences Biotech, Hangzhou, China).
Cell lines and culture
Human lung cancer A549 cell line was purchased from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. A549/TAX cells were purchased from Shanghai MEIXUAN Biological Science and Technology Co, Ltd. A549 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and penicillin (100 U/mL)/ streptomycin (100 U/mL). A549/TAX cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) and penicillin (100 U/mL)/streptomycin (100 U/mL) and 200 ng/mL paclitaxel at 37 °C in a humidified atmosphere with 5%
Quantitative qPCR analyses of miRNA-200c amplifications qPCR was performed in an ABI7500 thermocycler with 7500 software v2.03 (Life Technologies Corporation). miRNA quantification: Bulge-loop TM miRNA qRT-PCR Primer Sets (one RT primer and a pair of qPCR primers for each set) specific for miRNA is designed by RiboBio (Guangzhou, China).
siRNA transfection miRNA-200c mimic, miRNA-200c inhibitor, and negative control were obtained from RiboBio (Guangzhou, China). siRNA was mixed with Lipofectamine ® 3000 Reagent (Invitrogen) and transfected into A549 and A549/TAX cells. After 6 h, the supernatant was replaced with a fresh medium containing 10% FBS and cultured for another 24 h. siRNA sequences were then used for transfection as follows. miRNA-200c mature chain sequence: 5'-UAAUACUGCCGGGUAAUGAUGGA-3'.
Wound-healing assay Cells were grown in six-well plates. After achieving confluency, the cells were scratched with a vpipette tip, rinsed to remove debris, and further incubated with fresh FBS-free culture medium for 24 h. Cell migration images were captured at 0 and 24 h. Wound-healing index, which was determined as percentage, was quantitatively analyzed by using 20 randomly selected distances across the wound at 0 and 24 h and divided by the distance measured at 0 h.
Transwell invasion assay
Invasion assay was performed using 24-well Matrigel invasion chambers (BD Biosciences). The cells were trypsinized and reseeded in the upper chamber at a concentration of 1×10 5 /mL in 200 µL of FBS-free DMEM. The lower chamber was composed of 800 µL of DMEM and supplemented with 10% FBS. After 24 h, the cells on the upper surface of the filters were removed, while the cells on the lower surface were fixed with methanol and stained with crystal violet.
Actin cytoskeleton staining Cells were grown on coverslips, fixed with 4% fresh paraformaldehyde for 10 min at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 20 min, and blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. These cells were subsequently stained with fluorescein isothiocyanate (FITC)-phalloidin for 2 h at room temperature in the dark, washed, and counterstained with DAPI for 10 min. Confocal microscopy (Carl Zeiss, LSM 710) was employed to observe F-actin distribution.
Cytotoxicity assay
Methyl thiazolyl tetrazolium (MTT) was used to determine cell viability and proliferation. A549 cells and A549/PTX cells were transfected with miRNA and seeded into 96-well plates at a density of 10 4 cells per well. The cells were cultured for 24 h in 100 μL of complete DMEM. After the cells were pre-treated with different paclitaxel concentrations for 24 h, 10 μL of MTT solution (5 mg/mL) was added to each well and incubated for 4 h at 37 °C, and 100 μL of 1% acid was added to each well to dissolve blue formazan crystals. Optical density was measured at 570 nm. These assays were performed in triplicate.
Western blot analysis
Cells were harvested using a plastic scraper, washed twice with cold PBS, and homogenized in lysis buffer. Protein lysates were quantified using a BCA protein assay kit (Thermo Scientific), loaded, and separated on 10% or 8% SDS-PAGE gels. The proteins were transferred onto nitrocellulose blotting membranes. These membranes were blocked with 5% milk-TBST for 1 h, incubated with primary antibodies overnight, and washed thrice. Afterward, the blots were incubated with secondary antibodies for 1 h. Immunoblots were detected in Odyssey Infrared Imaging System (Li-COR Biosciences, Lincoln, NE, USA).
Lentivirus transduction A549 cells were seeded in six-well plates in DMEM supplemented with 10% FBS. The cells were treated with 2×10 7 titration units of lentivirus packaging 24 h after seeding and synthesized by GeneChem (Shanghai, China). Polybrene (5 ng/μL) was added to enhance the efficiency of viral infections. The cells were harvested 4 d after infection for either RNA extraction or protein lysate preparation.
Immunofluorescence staining
The cells were treated 1 d after they were seeded on coverslips as required for the experiment, fixed with methanol for 10 min at 4 °C, and permeabilized for 10 min with 0.1% Triton X-100. Afterward, the cells were incubated for 1 h in blocking buffer (1% BSA and 0.1% Triton X-100) at 4 °C. For immunofluorescence, the cells were incubated with antibodies against E-cadherin, N-cadherin, and vimentin at 4 °C overnight. Subsequently, the cells were rinsed thrice with PBS and incubated with the appropriate biotinylated secondary antibodies for 1 h. Alexa Fluor 488 (Molecular Probes, 1:500) and Alexa Fluor 594 goat anti-mouse (Molecular Probes, 1:500) antibodies were used as tertiary antibodies for 1 h. Then, the cells were counterstained with 0.5 ng/mL DAPI for 15 min at room temperature, and coverslips were mounted on slides with a VECTASHIELD mounting medium for fluorescence and analysis through confocal microscopy.
Hoechst 33258 staining
The treated cells were analyzed using a Hoechst staining kit (Sigma). Staining was performed in accordance with the manufacturer's protocol. The cells were washed with PBS, treated with a fixing solution for 10 min, and stained with Hoechst 33258 fluorescent dye for 10 min at room temperature. Morphological nuclear changes were observed and captured using an inverted fluorescence microscope.
Flow cytometry analysis
The percentage of apoptotic cells was measured using an Annexin V-(FITC)/PI apoptosis detection kit (KeyGen, Nanjing, China). A total of 10 000 cells per sample were examined with a FACSCalibur flow cytometer.
Statistical analysis
Data were expressed as mean±SD, and at least three independent experiments were performed. Differences in the measured variables between experimental and control groups were assessed using Student's t-test. P<0.05 was considered statistically significant. All analyses were performed using GraphPad Prism 5.0.
Results
Feedback loop between CTSL and miRNA-200c
The miRNA-200c expression was detected through qPCR. The average expression of miRNA-200c was significantly lower in A549/TAX cells, which are paclitaxel-resistant A549 cells, than in A549 cells ( Figure 1A ). This observation demonstrated that the miRNA-200c expression was downregulated in A549/TAX cells. We then examined the expression of CTSL in these two lung cancer lines ( Figure 1B ) and found that the CTSL protein levels were higher in A549/TAX cells than in A549 cells. This finding indicated that CTSL might be related to miRNA-200c to some extent.
To further investigate the potential links between CTSL and miRNA-200c, we silenced CTSL in A549/TAX cells and overexpressed CTSL in A549 cells through lentivirus transduction. As shown in Figure 1C Figure 1E ). Therefore, these results indicated that miRNA-200c and CTSL were reciprocally linked in a feedback loop.
miRNA-200c attenuated paclitaxel resistance in A549 cells
Considering that miRNA-200c is associated with the development of chemotherapy resistance [29, 33] , we hypothesized that miRNA-200c may modulate drug resistance in A549 cells. 
miRNA-200c was involved in the progression of CTSL-mediated drug resistance in A549 cells
Our previous work demonstrated that CTSL can regulate drug resistance by mediating EMT through its effects on the expression of EMT-associated transcription factors, such as Snail, Slug, ZEB1, and ZEB2 [12] . Therefore, we hypothesized that whether miRNA-200c can reverse paclitaxel resistance which induced by CTSL. To confirm this hypothesis, we silenced CTSL in A549/TAX cells and overexpressed CTSL in A549 cells through lentivirus transduction. We then inhibited or overexpressed miRNA-200c in these two cells. Then, we determined the effect of CTSL knockdown and miRNA-200c inhibition on IC 50 an aggressive and invasive phenotype in prostate cancer [34] . Consistent with our previous findings [12] , this phenomenon illustrates a possible relationship between drug resistance and invasive potential. Our study hypothesized that miRNA200c can regulate paclitaxel resistance by inhibiting cell invasion and migration. To verify this hypothesis, we conducted wound-healing and Transwell assays to detect the effects of miRNA-200c on cell invasion and migration. The results showed that miRNA-200c knockdown enhanced the invasion and migration of A549 cells, and miRNA-200c overexpression decreased the invasion and migration of A549/TAX cells ( Figure 4A and 4B) . Furthermore, the suppression of miRNA200c noticeably induced an increase in lamellipodia and stress fibers in A549 cells. The overexpression of miRNA-200c evidently suppressed actin remodeling associated with A549/ TAX cells motility ( Figure 4C ). Therefore, miRNA-200c regulates paclitaxel resistance by suppressing cell invasion and migration.
CTSL cooperated with miRNA-200c to mediate cell invasion and migration To investigate the potential roles of CTSL and miRNA-200c in mediating cell invasion and migration, we overexpressed CTSL in A549 cells and inhibited CTSL in A549/TAX cells, then we subjected them to wound healing and Transwell assays. We observed that the overexpression of CTSL could induce the invasion and migration of A549 cells, and the suppression of CTSL could inhibit the invasion and migration of A549/TAX cells. Then, we transfected the miRNA200c mimic or inhibitor into these two cells and examined the cells through wound healing and transwell assays to evaluate cell migration and invasion. In Figure 5A and 5B, miRNA200c overexpression decreased the invasion and migration in CTSL-overexpressed A549 cells. By contrast, miRNA-200c suppression increased the invasion and migration in CTSLinhibited A549/TAX cells. These results indicated that CTSL and miRNA-200c could regulate paclitaxel resistance in A549 cells by controlling cell invasion and migration.
miRNA-200c played a vital role in mediating EMT in A549 cells
EMT is a key element in cell migration, invasion, and drug resistance in several cancer types [35] . Blocking and reversing EMT may be important strategies to overcome chemotherapy resistance. On the basis of the experimental results, we hypothesized that miRNA-200c could regulate drug resistance by mediating EMT. 
Discussion
The question addressed by the present study was whether an miRNA-200c link exists between CTSL expression and drug resistance. To address this question, we quantified CTSL and miRNA-200c levels in lung cancer cells and found that CTSL expression was inversely correlated with miRNA-200c expression. The forced CTSL expression in low-CTSL-expressing A549 cells inhibited the miRNA-200c expression, and the interference with CTSL expression in high-CTSL-expressing A549/TAX cells promoted the miRNA-200c expression. The miRNA-200c inhibitor evidently increased the CTSL expression in A549 cells, and the miRNA-200c mimic decreased the CTSL expression in A549/TAX cells. Therefore, we draw a conclusion that there are reciprocally linked in a feedback loop between CTSL and miRNA-200c. In addition, A549 cells harbors KRAS mutations, whereas miRNA-200c has been reported to target the KRAS gene [36] . Taken together, we selected another human lung cancer cell lines, H1299 cells with wild type KRAS, qRT-PCR results suggested that CTSL Chemotherapy plays an important role in lung cancer treatment, but the existence of drug resistance restricts therapeutic efficacy. Therefore, novel therapeutic targets must be developed to reinforce the efficacy of cancer chemotherapy. CTSL is implicated in malignant transformation [37] and is upregulated in various drug-resistant cancer cells. Studies have also proposed that CTSL is involved in the regulation of drug resistance. Zheng et al revealed that CTSL inhibition enhances the availability of cytoplasmic and nuclear protein drug targets, including estrogen receptor-α, Bcr-Abl, topoisomerase-IIα, histone deacetylase 1, and androgen receptor [9] . CTSL suppression also improves gefitinib resistance in non-small cell lung cancer [14] , and CTSL knockdown can increase the sensitivity of ovarian cancer cells to paclitaxel [38] . Our previous study also suggested that CTSL may be a novel therapeutic target to prevent tumor cells from becoming resistant to chemotherapy and to reinforce the efficiency of paclitaxel and cisplatin against lung cancer [12] . As previously reported, miRNA-200c and other factors in its regulatory pathway are correlated with chemoresistance [39, 40] . Chang et al reported that miRNA-200c regulates the sensitivity of chemotherapy to cisplatin in gastric cancer by possibly targeting RhoE [41] . Ma et al revealed that miR-200c overexpression can decrease the colony formation, invasion, and chemoresistance of PCSCs [42] . However, the exact role of miR-200c in mediating drug resistance in A549 cells, its relationship with CTSL, and its underlying mechanism have yet to be elucidated. In our studies, we confirmed that miRNA- Several mechanisms, including drug efflux, drug inactivation, drug target alteration, DNA damage repair, and cell death inhibition, promote or enable drug resistance [43] . The role of EMT in cancer drug resistance is an emerging research area [44, 45] . EMT has also been established as a mechanism that provides tumor cells with abilities essential for drug resistance [46, 47] . EMT presumably occurs through multiple signaling pathways affected by microenvironments. The identification of miRNAs that regulate multiple EMT pathways is also a useful approach that can reveal potential therapeutic targets to help improve clinical outcomes in cancer treatment. The repression of the transcription of miRNA-200 family members by Nanog in colon cancer cells induces EMT [48] , and smad3 can regulate EMT via the miRNA-200 pathway [49] . Our early research showed that CTSL downregulation inhibits EMT to suppress cancer invasion and migration [11] . Thus, we inferred that the effects of miRNA-200c and CTSL may regulate paclitaxel resistance by inhibiting EMT in A549 cells. Our results demonstrated that miRNA-200c inhibition decreased the sensitivity of A549 cells to paclitaxel by suppressing EMT and by increasing the expression of EMT-associated transcription factors. Otherwise, miRNA-200c overexpression increased the sensitivity of A549/TAX cells to paclitaxel and reversed the EMT phenotype. Furthermore, miRNA-200c suppressed paclitaxel resistance by inhibiting EMT in A549/TAX cells, which could be induced by CTSL.
EMT is an essential process in cancer drug resistance and is an emerging area in research. EMT-promoting transcription factors, such as Snail/Slug/Twist and ZEB1/2, directly bind to E-cadherin promoter and repress its transcription. EMT is involved in the activation of transcription factors that interact with epigenetic regulators to control the expression of EMT marker proteins [29] . Several transcription factors, such as those of the Snail/Slug family, Twist, and ZEB1/2, function as molecular switches for the EMT program [29] . EMT has also been established as a mechanism that provides tumor cells with abilities essential for paclitaxel resistance in many cells. ZEB2 is an important EMT-transcription factor, and in our laboratory, we have confirmed that CTSL is initially identified as a novel EMT regulator, it can regulate drug resistance by mediating EMT through its effects on the expression of EMT-associated transcription factors, Snail, Slug, ZEB1, and ZEB2 [11, 12] . Also miRNA-200 targets ZEB2, it functions as a key regulator of EMT in numerous cancers and promotes an epithelial phenotype by inhibiting several EMT genes, including ZEB1 and ZEB2 [50, 51] . miRNA-200c inhibits the resistance of A549/TAX cells to paclitaxel by inhibiting EMT whether by suppressing the expression of ZEB2. And, we just suggested that Snail was significantly involved in the regulation of EMT by CTSL and miRNA-200c, but further research should be performed to confirm that whether other EMT-associated transcription factors were involved in this progression.
In summary, our study confirmed that CTSL and miRNA200c were reciprocally linked in a feedback loop, and miRNA200c could inhibit the paclitaxel resistance of A549/TAX cells through mutual regulation with CTSL by inhibiting EMT. In the same context, our findings suggested that miRNA-200c might be a potential treatment for non-small lung cancer. In our previously study, we have performed luciferase reporter assay to study whether CTSL is direct or indirect target of miRNA-200c. We selected the nucleotides 164 from exon 8 of the CTSL 3'UTR, but the results shown that in these sequences of CTSL, the luminescence intensity was not changed. It suggested that CTSL may be indirect target of miRNA-200c, there may be another regulatory factors, such as smad2, snail, p300, MGMT [52] . It is reported that miRNA-200c could regulate the expression of MGMT via c-Myb [52] , and in our laboratory, we also found the expression of MGMT in A549/TAX cells was higher than A549 cells, maybe the effect of miRNA-200c to CTSL is through regulating the expression of MGMT. Future studies should also investigate whether known miRNAs are differentially expressed in A549 and A549/TAX cells, or whether other miRNAs can suppress paclitaxel resistance induced by CTSL.
Abbreviations CTSL, Cathepsin L; EMT, Epithelial-mesenchymal transition; PTX, Paclitaxel; ZEB1, Zinc Finger E-Box Binding Homeobox 1; ZEB2, Zinc Finger E-Box Binding Homeobox 2; A549/TAX, Paclitaxel-resistant A549 cells.
